Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
Review
. 2015 May;4(5):e28.
doi: 10.1038/emi.2015.28. Epub 2015 May 6.

The role of C5a in acute lung injury induced by highly pathogenic viral infections

Affiliations
Review

The role of C5a in acute lung injury induced by highly pathogenic viral infections

Renxi Wang et al. Emerg Microbes Infect. 2015 May.

Abstract

The complement system, an important part of innate immunity, plays a critical role in pathogen clearance. Unregulated complement activation is likely to play a crucial role in the pathogenesis of acute lung injury (ALI) induced by highly pathogenic virus including influenza A viruses H5N1, H7N9, and severe acute respiratory syndrome (SARS) coronavirus. In highly pathogenic virus-induced acute lung diseases, high levels of chemotactic and anaphylatoxic C5a were produced as a result of excessive complement activaiton. Overproduced C5a displays powerful biological activities in activation of phagocytic cells, generation of oxidants, and inflammatory sequelae named "cytokine storm", and so on. Blockade of C5a signaling have been implicated in the treatment of ALI induced by highly pathogenic virus. Herein, we review the literature that links C5a and ALI, and review our understanding of the mechanisms by which C5a affects ALI during highly pathogenic viral infection. In particular, we discuss the potential of the blockade of C5a signaling to treat ALI induced by highly pathogenic viruses.

Keywords: C5a; acute lung injury; pro-inflammatory cytokines.

PubMed Disclaimer

References

    1. Ackerman SK, Friend PS, Hoidal JR, Douglas SD. Production of C2 by human alveolar macrophages. Immunology. 1978;35:369–372. - PMC - PubMed
    1. Cole FS, Matthews WJ, Rossing TH, Gash DJ, Lichtenberg NA, Pennington JE. Complement biosynthesis by human bronchoalveolar macrophages. Clin Immunol Immunopathol. 1983;27:153–159. - PubMed
    1. Strunk RC, Eidlen DM, Mason RJ. Pulmonary alveolar type II epithelial cells synthesize and secrete proteins of the classical and alternative complement pathways. J Clin Invest. 1988;81:1419–1426. - PMC - PubMed
    1. Garcia CC, Weston-Davies W, Russo RC, et al. Complement C5 activation during influenza A infection in mice contributes to neutrophil recruitment and lung injury. PLoS One. 2013;8:e64443. - PMC - PubMed
    1. Sun S, Zhao G, Liu C, et al. Inhibition of Complement Activation Alleviates Acute Lung Injury Induced by Highly Pathogenic Avian Influenza H5N1 Virus Infection. Am J Respir Cell Mol Biol. 2013;49:221–230. - PubMed

Publication types